Key Details
Price
$0.59Annual ROE
-31.31%Beta
-0.17Events Calendar
Next earnings date:
May 15, 2025Recent quarterly earnings:
Nov 14, 2024Recent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Feb 15, 2024Analyst ratings
Recent major analysts updates
No data about analysts updates
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
TNF Pharmaceuticals doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
TNF Pharmaceuticals Announces Positive Clinical Data Supporting Clinical Trial Expansion
TNFA
businesswire.comJanuary 15, 2025
BALTIMORE--(BUSINESS WIRE)---- $TNFA--TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNFA” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel oral therapies for autoimmune and inflammatory conditions, today announced that it has achieved a key safety data milestone supporting expanded and longer-term clinical studies of its novel TNF-alpha (TNF-α) inhibitor drug, isomyosamine, in multiple indications. The Company successfully completed an FDA-recommended study of isom.
FAQ
- What is the ticker symbol for TNF Pharmaceuticals?
- Does TNF Pharmaceuticals pay dividends?
- What sector is TNF Pharmaceuticals in?
- What industry is TNF Pharmaceuticals in?
- What country is TNF Pharmaceuticals based in?
- Is TNF Pharmaceuticals in the S&P 500?
- Is TNF Pharmaceuticals in the NASDAQ 100?
- Is TNF Pharmaceuticals in the Dow Jones?
- When was TNF Pharmaceuticals's last earnings report?
- When does TNF Pharmaceuticals report earnings?
What is the ticker symbol for TNF Pharmaceuticals?
The ticker symbol for TNF Pharmaceuticals is NASDAQ:TNFA
Does TNF Pharmaceuticals pay dividends?
No, TNF Pharmaceuticals does not pay dividends
What sector is TNF Pharmaceuticals in?
TNF Pharmaceuticals is in the Healthcare sector
What industry is TNF Pharmaceuticals in?
TNF Pharmaceuticals is in the Biotechnology industry
What country is TNF Pharmaceuticals based in?
TNF Pharmaceuticals is headquartered in United States
Is TNF Pharmaceuticals in the S&P 500?
No, TNF Pharmaceuticals is not included in the S&P 500 index
Is TNF Pharmaceuticals in the NASDAQ 100?
No, TNF Pharmaceuticals is not included in the NASDAQ 100 index
Is TNF Pharmaceuticals in the Dow Jones?
No, TNF Pharmaceuticals is not included in the Dow Jones index
When was TNF Pharmaceuticals's last earnings report?
TNF Pharmaceuticals's most recent earnings report was on Nov 14, 2024
When does TNF Pharmaceuticals report earnings?
The next expected earnings date for TNF Pharmaceuticals is May 15, 2025